US Broker Ratings

Johnson & Johnson (JNJ) Stock Analysis: A Robust Healthcare Giant with a 2.51% Dividend Yield

Johnson & Johnson (NYSE: JNJ), a cornerstone in the healthcare sector, continues to capture investors’ attention with its impressive market capitalization of $498.53 billion and a broad range of innovative..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring Its 3.85% Potential Upside

For investors eyeing opportunities in the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) presents an intriguing case. As a globally recognized leader in the medical instruments and supplies industry,..

Merit Medical Systems (MMSI) Stock Analysis: 18.95% Potential Upside Beckons Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, continues to attract investor attention with its robust growth prospects and strong market presence. With a market..

The Ensign Group, Inc. (ENSG) Stock Analysis: Strong Revenue Growth and Attractive Upside

Investors seeking opportunities in the healthcare sector may find The Ensign Group, Inc. (NASDAQ: ENSG) an appealing prospect. As a key player in the medical care facilities industry, Ensign Group..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 33% Potential Upside in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX), with a market capitalization of $5.28 billion, is turning heads in the biotechnology industry thanks to its promising pipeline and compelling market positioning. As a..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 29.70% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, has been capturing investor attention with its innovative approach in the biotechnology sector. With a current market capitalization of $8.49 billion, this..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook with a 14.76% Potential Upside

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, continues to draw investor interest with its robust performance metrics and promising pipeline. With a market capitalization of $15.17..

HealthEquity (HQY) Stock Analysis: Exploring a Promising 14.41% Upside in the Burgeoning Healthcare Sector

HealthEquity, Inc. (NASDAQ: HQY) stands prominently in the healthcare sector, specializing in health information services. The company provides a range of technology-enabled platforms that facilitate health savings accounts, flexible spending..

Legend Biotech Corporation (LEGN) Stock Analysis: Unlocking a 170% Potential Upside with Cutting-Edge CAR-T Therapies

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, is drawing significant attention from investors with its potential for a remarkable 170% upside. With a current market..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Robust Growth Trajectory in Healthcare

Medpace Holdings, Inc. (NASDAQ: MEDP), a stalwart in the healthcare sector, specifically within the diagnostics and research industry, is marking its presence on the stock market with a notable market..

Globus Medical, Inc. (GMED) Stock Analysis: Riding the Wave of 22.9% Revenue Growth in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specializes in cutting-edge medical devices targeting musculoskeletal disorders. With a market capitalization of $12.3 billion, this Audubon, Pennsylvania-based..

Roivant Sciences Ltd. (ROIV) Stock Report: Analyzing a 17.95% Potential Upside for Biotech Investors

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, has drawn significant attention from investors eyeing the healthcare industry. Based in London, this clinical-stage biopharmaceutical company is..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth in the Global Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically in the drug manufacturing industry, is making strides in the global animal health market. With a..

Insmed Incorporated (INSM) Stock Analysis: Exploring Growth Potential in Biotechnology with a 52.4% Revenue Surge

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is drawing significant attention from investors, fueled by its robust revenue growth and promising drug pipeline. With a market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Giant with an 8% Upside Potential

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, operates within the diagnostics and research industry, boasting a market capitalization of $39.17 billion. With its headquarters in Durham,..

McKesson Corporation (MCK) Stock Analysis: Navigating Opportunities in Healthcare with a 6.09% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a key player in the medical distribution industry with a robust market capitalization of $109.6 billion. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Buy Ratings and Promising Growth in Oncology

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector with its keen focus on developing innovative oncology treatments. As a key player in the healthcare industry, Exelixis has carved..

Doximity, Inc. (DOCS): Investor Outlook with a 33% Upside Potential and Strong Market Position

Doximity, Inc. (DOCS), a prominent player in the healthcare sector, operates as a digital platform tailored for medical professionals in the United States. With a market capitalization of $9.68 billion,..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 23% Upside Potential Amidst Healthcare Sector Dynamics

Fresenius Medical Care AG (NYSE: FMS), a leading player in the healthcare sector specializing in renal care services, offers a compelling investment case for those focused on long-term growth opportunities...

Bio-Rad Laboratories, Inc. (BIO): Investor Outlook on Potential Upside and Market Position

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a significant player within the healthcare sector, specifically in the medical devices industry. With a robust market capitalization of $8.76 billion, the company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds